Turitz Andrew's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 5, 2024
- Accession no.
- 0001477449-24-000041
- Filed
- Mar 5, 2024
- Trade date
- Mar 1-4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 7 derivative transactions. Open-market sales total $97.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Turitz AndrewCIK 0001726221 | Officer (EVP, CORPORATE DEVELOPMENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | SSaleDisposed | −475 | $15.06 | −$7,153.5 | 25,193 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +4,226 | –F2 | – | 29,419 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +437 | –F2 | – | 29,856 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +867 | –F2 | – | 30,723 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +1,348 | –F3 | – | 32,071 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +12,400 | –F3 | – | 44,471 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +1,148 | –F3 | – | 45,619 | Direct | |
| Mar 4, 2024 | Common Stock | SSaleDisposed | −6,190 | $14.52 | −$89,878.8 | 39,429 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +12,679 | $0.00 | $0 | 12,679 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −4,226 | $0.00 | $0 | 8,453 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −437 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −867 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −1,348 | $0.00 | $0 | 5,392 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −12,400 | $0.00 | $0 | 24,802 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −1,148 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Performance stock units convert to shares of TDOC common stock on a one-for-one basis
Referenced by the price of 3 transactions in Table I.
- F3
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.